This innovative anti-cancer treatment provides new hope to patients with multiple myeloma, a common form of blood cancer.
A novel cancer drug called Xpovio was recently approved by the Food and Drug Administration in the U.S., providing a ray of hope for patients with multiple myeloma, a type of blood cancer that claimed the lives of 100,000 people worldwide in 2015.
This potentially life-changing medicine was developed by a company started by Israeli researcher Dr. Sharon Shacham.
Way to go Dr. Shacham and way to go Israel!